L-P Xu

1.2k total citations
17 papers, 907 citations indexed

About

L-P Xu is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, L-P Xu has authored 17 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in L-P Xu's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (6 papers) and Immune Cell Function and Interaction (5 papers). L-P Xu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (6 papers) and Immune Cell Function and Interaction (5 papers). L-P Xu collaborates with scholars based in China. L-P Xu's co-authors include Xiao‐Jun Huang, D-H Liu, K-Y Liu, Y-H. Chen, JZ Wang, Hui Chen, D-P Lu, Wei Han, Qian Jiang and Gao Zy and has published in prestigious journals such as Leukemia, Clinical & Experimental Immunology and Bone Marrow Transplantation.

In The Last Decade

L-P Xu

17 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L-P Xu China	15	804	349	263	239	77	17	907
K-Y Liu China	17	981 1.2×	432 1.2×	298 1.1×	257 1.1×	96 1.2×	20	1.1k
Connie A. Sizemore United States	9	767 1.0×	351 1.0×	213 0.8×	279 1.2×	56 0.7×	26	817
Angéla Granata France	19	679 0.8×	306 0.9×	186 0.7×	300 1.3×	105 1.4×	61	863
D-H Liu China	18	1.0k 1.2×	440 1.3×	311 1.2×	279 1.2×	108 1.4×	23	1.2k
Douglas Rizzo United States	4	566 0.7×	198 0.6×	190 0.7×	137 0.6×	58 0.8×	8	675
Shannon R. McCurdy United States	17	602 0.7×	266 0.8×	150 0.6×	219 0.9×	56 0.7×	70	737
David Stroncek United States	7	688 0.9×	349 1.0×	139 0.5×	183 0.8×	81 1.1×	15	834
Luís Fernando S. Bouzas Brazil	13	627 0.8×	248 0.7×	163 0.6×	182 0.8×	76 1.0×	27	868
James Gajewski United States	11	635 0.8×	338 1.0×	154 0.6×	246 1.0×	59 0.8×	13	852
W-S Min South Korea	15	572 0.7×	145 0.4×	255 1.0×	143 0.6×	111 1.4×	29	737

Countries citing papers authored by L-P Xu

Since Specialization

Citations

This map shows the geographic impact of L-P Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L-P Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L-P Xu more than expected).

Fields of papers citing papers by L-P Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L-P Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L-P Xu. The network helps show where L-P Xu may publish in the future.

Co-authorship network of co-authors of L-P Xu

This figure shows the co-authorship network connecting the top 25 collaborators of L-P Xu. A scholar is included among the top collaborators of L-P Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L-P Xu. L-P Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Xu, L-P, Zhiliang Xu, W Han, et al.. (2018). Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia. Bone Marrow Transplantation. 53(2). 188–192. 25 indexed citations

Xu, L-P, Dapeng Wu, Hsu‐Shan Huang, et al.. (2017). A review of hematopoietic cell transplantation in China: data and trends during 2008–2016. Bone Marrow Transplantation. 52(11). 1512–1518. 59 indexed citations

Wu, Dapeng, Q-F Liu, L-P Xu, et al.. (2017). Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants. Leukemia. 32(2). 492–498. 48 indexed citations

Yang, Xin, Xiaodong He, Junping Wei, et al.. (2017). Hormone therapy for premature ovarian insufficiency patients with malignant hematologic diseases. Climacteric. 20(3). 268–273. 16 indexed citations

Wang, Y, Dapeng Wu, Ming Jiang, et al.. (2016). Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant. Leukemia. 30(10). 2055–2063. 81 indexed citations

Xu, L-P, Zhang Xiu, Y Wang, et al.. (2016). Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation. Bone Marrow Transplantation. 52(3). 409–414. 12 indexed citations

Liu, D-H, Y-H. Chen, L-P Xu, et al.. (2014). Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignances. Bone Marrow Transplantation. 49(8). 1070–1075. 29 indexed citations

Xu, L-P, et al.. (2014). Presence of CD34+CD38−CD58− leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT. Bone Marrow Transplantation. 50(3). 348–353. 8 indexed citations

Xu, L-P, Zhang Xiu, D-H Liu, et al.. (2014). Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome. Bone Marrow Transplantation. 50(1). 127–133. 40 indexed citations

10.

Liu, D-H, L-P Xu, K-Y Liu, et al.. (2013). Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia. Bone Marrow Transplantation. 48(12). 1519–1524. 35 indexed citations

11.

Xu, L-P, D-H Liu, Y-H. Chen, et al.. (2012). Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT. Bone Marrow Transplantation. 47(9). 1201–1205. 34 indexed citations

12.

Wang, Y, D-H Liu, L-P Xu, et al.. (2011). Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis. Bone Marrow Transplantation. 47(8). 1099–1104. 54 indexed citations

13.

Liu, K-Y, et al.. (2011). High frequencies of CD62L+ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation. Clinical & Experimental Immunology. 165(2). 264–277. 32 indexed citations

14.

Huang, Xiao‐Jun, D-H Liu, L-P Xu, et al.. (2009). Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect. Bone Marrow Transplantation. 44(5). 309–316. 48 indexed citations

15.

Xu, L-P, K-Y Liu, D-H Liu, et al.. (2009). The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis. Bone Marrow Transplantation. 45(6). 985–992. 31 indexed citations

16.

Chang, Ya‐Jen, et al.. (2009). Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors. Bone Marrow Transplantation. 44(11). 721–728. 23 indexed citations

17.

Huang, Xiao‐Jun, D-H Liu, K-Y Liu, et al.. (2006). Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplantation. 38(4). 291–297. 332 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact